Adcendo
Adcendo is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for treating underserved cancers. Their focus is on first-in-class ADCs to address cancers with high unmet medical needs. The company aims to significantly change treatment paradigms through its innovative ADC pipeline.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $135M
Date: 25-Nov-2024
Investors: TCGX, TPG Life Sciences Innovations, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital, Logos Capital, RA Capital Management, Novo Holdings, Pontifax Venture Capital, Dawn Biopharma, KKR, HealthCap, Gilde Healthcare, Ysios Capital
Markets: Biotechnology, Oncology, Pharmaceuticals, Biotechnology Research
HQ: Frederiksberg, Capital Region of Denmark, Denmark
Founded: 2017
Website: https://www.adcendo.com/
LinkedIn: https://www.linkedin.com/company/adcendo/
Crunchbase: https://www.crunchbase.com/organization/adcendo
Leave a Comment
Comments
No comments yet.